Related references
Note: Only part of the references are listed.Epidemiologic features of 348 children with hepatitis C virus infection over a 30-year period: a nationwide survey in Japan
Tatsuki Mizuochi et al.
JOURNAL OF GASTROENTEROLOGY (2018)
Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBV
Chun-Jen Liu et al.
GASTROENTEROLOGY (2018)
Efficacy of Ledipasvir Plus Sofosbuvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2 Infection
Edward J. Gane et al.
GASTROENTEROLOGY (2017)
ITPA gene variation and ribavirin-induced anemia in patients with genotype 2 chronic hepatitis C treated with sofosbuvir plus ribavirin
Miyako Murakawa et al.
HEPATOLOGY RESEARCH (2017)
JSH Guidelines for the Management of Hepatitis C Virus Infection: A 2016 update for genotype 1 and 2
Yasuhiro Asahina et al.
HEPATOLOGY RESEARCH (2016)
Adverse events associated with ribavirin in sofosbuvir-based therapies for patients with chronic hepatitis C: A community practice experience
Myron John Tong et al.
JOURNAL OF DIGESTIVE DISEASES (2016)
A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection
Jia-Horng Kao et al.
LIVER INTERNATIONAL (2016)
Changes in hepatitis C virus genotype distribution in Japan
H. Toyoda et al.
EPIDEMIOLOGY AND INFECTION (2014)
Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open-label, phase 3 trial
Masao Omata et al.
JOURNAL OF VIRAL HEPATITIS (2014)
Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
Nezam Afdhal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3
Stefan Zeuzem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Efficacy and safety of peginterferon plus ribavirin for patients aged ≥ 65 years with chronic hepatitis C: A systematic review and meta-analysis
Zongguo Yang et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2014)
Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
Ira M. Jacobson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
Eric Lawitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt
William Sievert et al.
LIVER INTERNATIONAL (2011)
Changing Trends in Hepatitis C Infection over the Past 50 Years in Japan
Hobyung Chung et al.
INTERVIROLOGY (2010)
Hepatitis C in 6,865 patients 65 yr or older: A severe and neglected curable disease?
Dominique Thabut et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Spread times of hepatitis C virus estimated by the molecular clock differ among Japan, the United States and Egypt in reflection of their distinct socioeconomic backgrounds
M Mizokami et al.
INTERVIROLOGY (2005)
Molecular epidemiologic analysis of hepatitis C virus infection in injecting drug users with acute hepatitis C in Japan
Y Satoh et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2004)
Sex- and age-specific carriers of hepatitis B and C viruses in Japan estimated by the prevalence in the 3,485,648 first-time blood donors during 1995-2000
J Tanaka et al.
INTERVIROLOGY (2004)
Share Paper
